Home
/
Products
/
Services
/
Resource
Citations Database
Download
/
News
/
Genomeditech
About
History
Honor
Contact
Careers
/
Activity
EN
EN
CN
Lentivirus
过表达慢病毒
干扰慢病毒
Cell Line Development
过表达细胞系构建服务
敲低细胞系构建服务
敲除细胞系构建服务
报告基因细胞株构建服务
Luciferase标记细胞株
Protein Expression
Plasmid DNA Preparation Services
过表达质粒构建
干扰质粒构建
突变/截短质粒构建
荧光素酶报告基因质粒构建
Adeno-associated Virus
过表达AAV
干扰AAV
Cell-based Assay
抗体Binding检测
蛋白/抗体药物功能检测
ADCC/P 活性检测
ADC药物CTG杀伤检测
CCK8细胞增值检测
克隆形成
细胞迁移/侵袭
细胞周期/凋亡
划痕实验
Antibody Services
Reporter Gene Detection Services
miRNA与靶基因调控研究
转录因子调控/promoter活性研究
Plasmid
Stock Plasmid
Reporter Plasmid
Autophagy Fluorescent Single-Tag Plasmid
Empty Vector
Cell Tracking Plasmid
iPS-Related Plasmids
Cell Lines
Antibody Related
Cas9
Cell Tracing
Cytokines
GPCR
Immune Checkpoint
Immunology
In Vivo Imaging
Kinase
Metabolism
Molecular-Reference-Standards
Nuclear Receptors
PRR Signalings
Pseudovirus
TLR
TNF Superfamily
Transcription Factor
Tumor-Associated Antigen(TAA)
Others
Molecular Reference Standards
gDNA
ctDNA
Reporter gene detection-related reagents
GMOne-Step
GMOne-Step 2.0
GMBright One-Step
GMSteady One-Step
Dual Luciferase Reporter Gene Assay Kit
D-Luciferin
Lentivirus
Overexpression Lentivirus
Reporter Lentivirus
In Vivo Imaging Lentivirus
iPS-Related Lentivirus
Immortalization Lentivirus
Autophagy Lentivirus
Cre Lentivirus
Fluorescent Control Lentivirus
Proteins
ADC Internalization
Antibody Related
Cytokines
GPCR
Immune Checkpoint
Immunology
Kinase
Metabolism
Others
PRR signalings
Tumor-Associated Antigen(TAA)
TNF Superfamily
Pseudovirus control material
Coronavirus-Like Pseudovirus
Influenza-Like Pseudovirus
Parainfluenza-Like Pseudovirus
Respiratory Syncytial Virus-Like Pseudovirus
Rhinovirus-Like Pseudovirus
Human Metapneumovirus-Like Pseudovirus
Monkeypox-Like Pseudovirus
Reagents related to cell function detection and analysis
GMTiter TM Luminescent Cell Viability Assay
Cell Counting kit-8
Adeno-Associated Virus (AAV)
Optogenetics
Chemical Genetics
Calcium Imaging
Cre Recombinase
Standard Control Vectors
Antibodies
Biosimilar Antibodies
ADC Antibodies
In Vivo MAb Antibodies
Virus neutralizing antibodies
Antibody Related
Tag Antibodies/Loading Controls Antibodies
Pseudovirus
SARS-CoV-2 pseudovirus
Rabies Pseudovirus
SARS Pseudovirus
Influenza pseudovirus
MERS pseudovirus
HIV-1 Pseudovirus
Genoagent (Brand name of reagents)
lentiviral-packaging-tool
Transfection Reagent
Mycoplasma Removal Reagent
Antibiotic
Gene Knockout Kit
Polybrene
Switch-On Reagent
Staphylococcal Enterotoxin E
News
Insights
Resources
Activity
Search
CN
Search
Home
Products
Plasmid
Cell lines
Molecular Reference Standards
Reporter gene detection-related reagents
Lentivirus
Proteins
Pseudovirus control material
Reagents related to cell function detection and analysis
Adeno-Associated Virus (AAV)
Antibodies
Pseudovirus
Genoagent (Brand name of reagents)
Services
Lentivirus
Adeno-associated Virus
Cell Line Development
Cell-based Assay
Plasmid DNA Preparation Services
Protein Expression
Antibody Services
Reporter Gene Detection Services
Resource
Citations Database
Download
News
News
Genomeditech
About
History
Honor
Contact
Careers
Activity
Get A Quote
News
Insights
Resources
Activity
Current position:
News
>
News
> Insights
Insights
FDA approves penpulimab-kcqx for non-keratinizing nasopharyngeal carcinoma
2025-04-25
GLP-1:Novo Nordisk submits for FDA approval of oral GLP-1 obesity drug
2025-04-25
DLL4 Breakthrough in Cancer Therapy: Tovecimig Shows Promise for Biliary Tract Cancer!
2025-04-17
TL1A:Teva and Sanofi Announce Duvakitug Positive Phase 2b Results Demonstrating Best-in-Class Potential in Ulcerative Colitis and Crohn’s Disease
2025-02-10
IL-23:FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease
2025-01-17
Amgen’s IMDYLLTRA®▼ (tarlatamab) Granted a Conditional Marketing Authorisation for Third-Line Treatment of Extensive-Stage Small Cell Lung Cancer in the United Kingdom
2025-01-17
GLP:Eden Unveils the World's First Compounded GLP-1 Rx Gummy
2025-01-10
TL1A:Teva and Sanofi Announce Duvakitug (Anti-TL1A) Positive Phase 2b Results Demonstrating Best-in-Class Potential in Ulcerative Colitis and Crohn’s Disease
2024-12-19
Merck Enters into Exclusive Global GLP-1:License Agreement with Hansoh Pharma for Investigational Oral GLP-1 Receptor Agonist
2024-12-19
ROR1:Merck Sharp & Dohme Initiates Phase III Clinical Trial of ROR1 ADC
2024-12-06
First
Prev
3
4
5
6
7
Next
Last
Total 7 Page
Jump
Current position:
News
>
News
> Insights
classify
Insights
FDA approves penpulimab-kcqx for non-keratinizing nasopharyngeal carcinoma
2025-04-25
GLP-1:Novo Nordisk submits for FDA approval of oral GLP-1 obesity drug
2025-04-25
DLL4 Breakthrough in Cancer Therapy: Tovecimig Shows Promise for Biliary Tract Cancer!
2025-04-17
TL1A:Teva and Sanofi Announce Duvakitug Positive Phase 2b Results Demonstrating Best-in-Class Potential in Ulcerative Colitis and Crohn’s Disease
2025-02-10
IL-23:FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease
2025-01-17
Amgen’s IMDYLLTRA®▼ (tarlatamab) Granted a Conditional Marketing Authorisation for Third-Line Treatment of Extensive-Stage Small Cell Lung Cancer in the United Kingdom
2025-01-17
GLP:Eden Unveils the World's First Compounded GLP-1 Rx Gummy
2025-01-10
TL1A:Teva and Sanofi Announce Duvakitug (Anti-TL1A) Positive Phase 2b Results Demonstrating Best-in-Class Potential in Ulcerative Colitis and Crohn’s Disease
2024-12-19
Merck Enters into Exclusive Global GLP-1:License Agreement with Hansoh Pharma for Investigational Oral GLP-1 Receptor Agonist
2024-12-19
ROR1:Merck Sharp & Dohme Initiates Phase III Clinical Trial of ROR1 ADC
2024-12-06
MORE
News
Insights
Resources
Activity
Message consultation
reset
submit
Message
Message consultation
reset
submit